Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million.
Therapeutics Company Announces Royalty Sale For Up To $31.5 Million
Therapeutics Company Announces Royalty Sale…
Therapeutics Company Announces Royalty Sale For Up To $31.5 Million
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million.